Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers.
The Oncologist
Hirshfield, Kim M KM; Tolkunov, Denis D; Zhong, Hua H; Ali, Siraj M SM; Stein, Mark N MN; Murphy, Susan S; Vig, Hetal H; Vazquez, Alexei A; Glod, John J; Moss, Rebecca A RA; Belyi, Vladimir V; Chan, Chang S CS; Chen, Suzie S; Goodell, Lauri L; Foran, David D; Yelensky, Roman R; Palma, Norma A NA; Sun, James X JX; Miller, Vincent A VA; Stephens, Philip J PJ; Ross, Jeffrey S JS; Kaufman, Howard H; Poplin, Elizabeth E; Mehnert, Janice J; Tan, Antoinette R AR; Bertino, Joseph R JR; Aisner, Joseph J; DiPaola, Robert S RS; Rodriguez-Rodriguez, Lorna L; Ganesan, Shridar S
Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.
Plos One
Churi, Chaitanya R CR; Shroff, Rachna R; Wang, Ying Y; Rashid, Asif A; Kang, HyunSeon C HC; Weatherly, Jacqueline J; Zuo, Mingxin M; Zinner, Ralph R; Hong, David D; Meric-Bernstam, Funda F; Janku, Filip F; Crane, Christopher H CH; Mishra, Lopa L; Vauthey, Jean-Nicholas JN; Wolff, Robert A RA; Mills, Gordon G; Javle, Milind M